Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21076464.
- Also identified by DOI 10.1038/modpathol.2010.200.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Breast cancer is a heterogeneous disease encompassing a variety of entities with distinct morphological features and clinical behaviors. Although morphology is often associated with the pattern of molecular aberrations in breast cancers, it is also clear that tumors of the same histological type show remarkably different clinical behavior. This is particularly true for 'basal-like cancer', which is an entity defined using gene expression analysis. The purpose of this article was to review the current state of knowledge of basal-like breast cancers, to discuss the relationship between basal-like and triple-negative breast cancers, and to clarify practical implications of these diagnoses for pathologists and oncologists.
Medical subject headings
- Biomarkers, Tumor
- Breast Neoplasms
- Neoplasms, Basal Cell